Cargando…
Vascular Diseases In Patients With Chronic Myeloproliferative Neoplasms – Impact Of Comorbidity
BACKGROUND: Patients with chronic myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF), are at high risk of vascular complications. However, the magnitude of this is risk not well known and the possible effect of comor...
Autores principales: | Frederiksen, Henrik, Szépligeti, Szimonetta, Bak, Marie, Ghanima, Waleed, Hasselbalch, Hans Carl, Christiansen, Christian Fynbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830370/ https://www.ncbi.nlm.nih.gov/pubmed/31807079 http://dx.doi.org/10.2147/CLEP.S216787 |
Ejemplares similares
-
Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study
por: Christensen, Sarah Friis, et al.
Publicado: (2022) -
Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms
por: Holmström, Morten Orebo, et al.
Publicado: (2020) -
Myeloproliferative neoplasms in five multiple sclerosis patients()
por: Thorsteinsdottir, Sigrun, et al.
Publicado: (2013) -
Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
por: Liisborg, Charlotte, et al.
Publicado: (2020) -
Risk of Inflammatory Bowel Disease in Patients with Chronic Myeloproliferative Neoplasms: A Danish Nationwide Cohort Study
por: Bak, Marie, et al.
Publicado: (2020)